You just read:

Araim Pharmaceuticals Obtains Fourth Orphan Designation: ARA 290 Obtains US Orphan Drug Designation for Treatment to Increase Survival and Improve Functioning of Pancreatic Islets Following Transplantation

News provided by

Araim Pharmaceuticals, Inc.

25 Jul, 2016, 01:00 ET